Vivencio Vicente
Barrios Alonso
Profesor/a Asociado/a en CC. de la Salud
![Foto de Vivencio Vicente](/img/nophoto.png)
![Foto de Universidad de Córdoba](/img/noimage_org.png)
Universidad de Córdoba
Córdoba, EspañaUniversidad de Córdoba-ko ikertzaileekin lankidetzan egindako argitalpenak (5)
2023
-
Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban
Journal of comparative effectiveness research, Vol. 12, Núm. 3, pp. e220049
2022
-
Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study
Cardiology Journal, Vol. 29, Núm. 6, pp. 936-947
-
Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study
Cardiology Journal, Vol. 29, Núm. 4, pp. 601-609
-
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry
European heart journal. Cardiovascular pharmacotherapy, Vol. 9, Núm. 1, pp. 38-46
-
Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries
Journal of comparative effectiveness research, Vol. 11, Núm. 16, pp. 1173-1184